Schizophrenia is increasingly recognized as a disorder of distributed neural dynamics, but the molecular and genetic contributions are poorly understood. Recent work highlights a role for altered N-methyl-D-aspartate (NMDA) receptor signaling and related impairments in the excitation-inhibitory balance and synchrony of large-scale neural networks. Here, we combined a pharmacological intervention with novel techniques from dynamic network neuroscience applied to functional magnetic resonance imaging (fMRI) to identify alterations in the dynamic reconfiguration of brain networks related to schizophrenia genetic risk and NMDA receptor hypofunction. We quantified "network flexibility," a measure of the dynamic reconfiguration of the community structure of time-variant brain networks during working memory performance. Comparing 28 patients with schizophrenia, 37 unaffected first-degree relatives, and 139 healthy controls, we detected significant differences in network flexibility [F(2,196) = 6.541, P = 0.002] in a pattern consistent with the assumed genetic risk load of the groups (highest for patients, intermediate for relatives, and lowest for controls). In an observer-blinded, placebo-controlled, randomized, cross-over pharmacological challenge study in 37 healthy controls, we further detected a significant increase in network flexibility as a result of NMDA receptor antagonism with 120 mg dextromethorphan [F(1,34) = 5.291, P = 0.028]. Our results identify a potential dynamic network intermediate phenotype related to the genetic liability for schizophrenia that manifests as altered reconfiguration of brain networks during working memory. The phenotype appears to be influenced by NMDA receptor antagonism, consistent with a critical role for glutamate in the temporal coordination of neural networks and the pathophysiology of schizophrenia.
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dynamic network neuroscience | schizophrenia | NMDA receptor function | intermediate phenotype | working memory S chizophrenia is a highly heritable mental disorder for which aberrant interactions between brain regions or "dysconnectivity" have been proposed as a core neural mechanism (1). Functional magnetic resonance imaging (fMRI) studies demonstrate alterations in specific neural subcircuits in schizophrenia (2, 3) that are under genetic control (4) , although recent data from network neuroscience point to more widespread disturbances in the dynamics of large-scale brain networks (5, 6). Uhlhaas (5), Uhlhaas and Singer (6) , and Phillips and Silverstein (7) have proposed a plausible pathophysiological mechanism for these phenomena: They argue that alterations in the cellular excitation-inhibitory balance may lead to disturbances in the neural synchrony of large-scale cell ensembles and give rise to the dysconnectivity phenomena at the level of neural ensembles.
The neural excitation-inhibitory balance is highly dependent on glutamatergic N-methyl-D-aspartate (NMDA) receptor function (8) , and alterations in NMDA receptor signaling have been associated with schizophrenia risk (9), disorder-related cognitive abnormalities (10, 11) , and deficits in the temporal coordination of large-scale brain networks (5, 6) . Theoretical work has related these dynamics to the generation of a "community architecture" of brain networks (12) . Communities are groups of interacting brain regions that are more tightly functionally related to each other than to the rest of the brain. Defined with established network neuroscience methods, they can be interpreted as a static representation of the partitioning of the brain into functional subnetworks. Indeed, alterations in the static network community structure have been observed in schizophrenia (13, 14) .
Recent developments in the evolving field of dynamic network neuroscience have extended these efforts by pioneering methods to assess the time-varying dynamics of community structure in large-scale brain networks (15) (16) (17) . Unlike the "static" network approaches, these methods allow for the quantification of contextdependent changes of the network community structure over time (e.g., during learning or cognitive load), which is arguably a biologically more accurate description of normal and disordered brain network dynamics (16, 18, 19) . Moreover, the temporal variability of the neural community structure predicts learning (16) and executive function (18) in normal volunteers, which are two established deficit areas in schizophrenia (20, 21) . The temporal dynamic thus appears to reflect the capacity of the brain connectome to configure flexibly in support of cognitive demands, a feature that may relate to the genetic risk architecture of schizophrenia. However, the clinical, genetic, and pharmacological implications of such a potential relationship remain unexplored.
Here, we apply dynamic network neuroscience methods to study the reconfiguration of large-scale brain networks during the n-back task, a robust working memory paradigm (22, 23 ) and well-established task for studying the neural basis of the cognitive deficits and the genetic risk architecture of schizophrenia (2) (3) (4) . We analyze brain regions (or nodes) and their interactions (or time-dependent edges) to identify densely interconnected communities (or coherent ensembles of brain regions) whose interactions change dependably during working memory performance. We quantify the dynamic changes in interactions using network flexibility, a measure of how often a brain region changes its allegiance to a community of nodes over time (Fig. 1) . We tested three specific hypotheses, namely, that alterations in dynamic community structure are present in schizophrenia, may relate to the genetic liability to the disorder, and can be modulated by the NMDA-dependent challenge of the excitatory-inhibitory balance of the network.
To test these hypotheses, we first examined whole-brain network flexibility in a sample of unaffected first-degree relatives of patients with schizophrenia (2) and compared the estimates with the estimates obtained from a cohort of patients with schizophrenia and from a large sample of healthy matched controls without a prior family history of mental illness. The study of healthy first-degree relatives of patients with schizophrenia is a particularly important strategy in the search for genetically influenced biological traits, because these individuals share an enriched set of schizophrenia risk variants but are devoid of confounding factors that interfere with fMRI readouts and complicate the interpretation of patient data (e.g., medication). We hypothesized that patients will show an increase in network flexibility consistent with prior theories positing a failure in the coordination of large-scale neural ensembles and the formation of a stable network community dynamic in schizophrenia (24) . Moreover, we expected to see similar alterations in network flexibility in the unaffected relatives, consistent with the idea of an intermediate phenotype reflecting the familial liability for schizophrenia.
Finally, to probe a plausible (patho)physiological mechanism of the expected altered network dynamics, we tested the effects of a single dose of the NMDA antagonist dextromethorphan (DXM) on network flexibility in an independent sample of healthy controls enrolled in an observer-blinded, placebo-controlled, randomized, cross-over pharmacological fMRI (phfMRI) experiment. We hypothesized that NMDA receptor blockade would result in a significant increase in network flexibility, consistent with a disturbance of the neural excitatory-inhibitory balance of neural networks (5, 6) and accepted theories on the role of NMDA receptor hypofunction in schizophrenia (25) .
Results
Demographics, Task Performance, Head Micromovement, and Image Quality. To examine the genetic underpinnings of alterations in the dynamic community structure, we examined the fMRI working memory data of an initial sample of 81 patients with schizophrenia, 50 unaffected first-degree relatives, and 165 healthy controls. Analyses were performed on a final sample of 28 patients with schizophrenia, 37 unaffected first-degree relatives, and 139 healthy controls after stringent head motion control and removal of individuals with more than 5% of scrubbed frames (Methods). Tables S1-S4 provide details on all variables of the final samples, including P values for the group comparisons. The relatives and control groups were well balanced for demographics, task performance, head micromovement, and image quality. The patient group was balanced for n-back task performance, head micromovement, and image quality, but differed significantly from the other two groups by a lower number of females and a lower premorbid intelligence level as quantified by the German multiple-choice vocabulary intelligence test (MWTB). Thus, we accounted for age, sex, premorbid intelligence, and site in all subsequent statistical comparisons. A more detailed clinical description of the patient sample is provided in Table S2 . Dynamic Network Community Structure During Working Memory. In line with our expectations, the unaffected first-degree relatives, patients with schizophrenia, and healthy controls were significantly different in network flexibility [F(2,196) = 6.541, P = 0.002]. Post hoc tests confirmed that both the relatives and patients with schizophrenia showed a significant increase in network flexibility relative to the controls [controls vs. relatives: P corrected (P corr ) = 0.017, controls vs. patients: P corr = 0.023]. Although the arrangement of group means was consistent with the assumed genetic risk load of the groups ( Fig. 2A) , the difference between the relatives and the patient group was not significant (P corr > 0.8).
Local Versus Global Changes. To examine if the observed average changes in network flexibility are driven by a biologically coherent subset of brain regions or are instead a general feature of dynamic network reconfiguration, we conducted two supplemental analyses. First, testing the average flexibility of 10 predefined functional systems described by Power et al. (26), we could not detect a significant main effect of systems or a significant interaction of group × systems [repeated measures ANOVA with system as a within factor; group as a betweensubject factor; and age, sex, site, and MWTB as covariates: main effect of system: F(9,1,764) = 1.37, P = 0.199; interaction system × group: F(18,1,764) = 1.34, P = 0.152], arguing for a brain-wide and not a system-specific effect (Fig. 2B) . Second, to support this notion further, we used random forest machine learning algorithms to identify optimally predictive combinations of node-wise flexibility measures. Flexibility measures were ranked based on their importance for accurate classification, and we used groupstratified cross-validation to explore classification accuracy for different numbers of the most highly ranked predictors. We observed that the classification accuracy remained similar when using 10, 30, or 50 nodes (accuracy of 61%, 64%, and 65%, respectively). The ranked variable importance did not indicate the presence of a well-localized and biologically meaningful set of predictive nodes (Fig. 2C) , with even the 10 most important nodes distributed among seven of 10 functional systems (visual system: four nodes; cinguloopercular system: two nodes; default mode and subcortical, frontoparietal, and sensory somatomotor systems: one node each), supporting our interpretation of a more generalized, system-level effect rather than a focal, subnetworkdependent effect. (For robustness of results to definition of parcellation and the edge-wise results, please see Figs. S1, S2, and S3.)
Relationship to Clinical State and Antipsychotic Medication. We did not detect a significant association between the network flexibility measure in the patient group and either chlorpromazine equivalents (27) (Spearman's rho = −0.145, P = 0.480), positive and negative syndrome scale scores (positive scale: Spearman's rho = 0.068, P = 0.730; negative scale: Spearman's rho = −0.008, P = 0.966), illness duration (Spearman's rho = −0.311, P = 0.159), or Wisconsin Card Sorting Test (WCST) performance (perseveration score: Spearman's rho = 0.244, P = 0.210). However, because our stringent matching procedure likely biased our patient sample toward a disproportionally higher rate of well-performing patients (thereby restricting clinically meaningful variance in the cognitive measures), we explored the association of network flexibility with cognition in the original, unmatched patient sample. Although we could not detect any significant association with the typically ceiling n-back task performance parameters (reaction time and task accuracy), we found a significant positive correlation with the perseveration score of the WCST (Spearman's rho = 0.314, P = 0.033) (28), a well-established clinical measure of cognitive flexibility. The correlation of the two measures is illustrated in Fig. S4C . To support our notion that the drug effect is also rather a brain-wide effect, we repeated our analysis, testing the average flexibility of 10 predefined functional systems. We detected no significant drug × system interaction [repeated measures ANOVA with system and drug as within factors and with age and sex as covariates; interaction system × drug: F(6.62,225.12) = 2.00, P = 0.06], again suggesting an effect that was not driven by a single focal system (Fig. 3B) . 
Discussion
The architecture of the human brain is intrinsically organized into time-varying assemblies of functionally interacting nodes (16, 18) , a dynamic neural community structure allowing for high adaptability of the system to changing environmental demands (29) . Schizophrenia is increasingly recognized as a heritable brain disorder with altered neural network dynamics, yet the presence of alterations in the time-varying configuration of the functional connectome and their genetic and pharmacological implications require clarification. To address this gap in knowledge, we conducted neuroimaging studies in which we applied innovative methods from dynamic network neuroscience to fMRI data acquired during the performance of an established working memory task. We report significant increases in brain network flexibility during working memory in patients with schizophrenia, their unaffected firstdegree relatives, and healthy individuals after pharmacological challenge with an NMDA receptor antagonist.
Our data extend the existing knowledge in network neuroscience in several notable directions. First, compared with healthy controls, the dynamic neural community structure of patients with schizophrenia showed an excess in flexibility in the working memory challenge. This observation extends prior network neuroscience data by demonstrating that in addition to the static network community structure (13, 14) , the dynamic configuration of neural assemblies is altered in schizophrenia. More specifically, consistent with prior accounts (30) , our data may indicate a temporally less stable, underconstrained, and possibly disintegrated (rather than overly rigid) network dynamic during working memory in schizophrenia. Importantly, the patient group was comparable to the controls for several potential confounds, including n-back task performance, head micromovement, and data quality measures, making these factors unlikely explanations for the outcome.
Second, we explored the neurogenetic basis of the dynamic neural network phenotype by studying healthy first-degree relatives of patients with schizophrenia relative to healthy controls without a family history of mental illness and to patients with schizophrenia. Compared with the controls, the relatives showed significant differences in dynamic network reconfiguration during working memory in a direction and magnitude that conform to the direction and magnitude of the patients. Healthy first-degree relatives are at increased risk for schizophrenia and share an enriched set of susceptibility variants with their affected family members (31) . However, the relatives are devoid of confounding influences that impact brain physiology and can complicate the interpretation of patient neuroimaging data, particularly the effects of medication, substance use, or illness chronicity. Importantly, our relatives group was comparable to the controls for several other potential confounders, including demographics, n-back task performance, head micromovement, and fMRI data quality. These results suggest that these factors are not likely explanations for the observed excess in neural network flexibility in the genetically and familial at-risk individuals. Instead, our data support the notion that this dynamic network alteration is familial and may relate to the genetic liability for schizophrenia. Although the relatives' data are the stronger evidence, the lack of correlations with antipsychotic drug dose and other clinical state measures in the patient group supports, at least indirectly, the idea that the dynamic network phenotype reflects a neurogenetic trait feature or "intermediate phenotype." This notion is further supported by the detected association between network flexibility and WCST perseveration score in the patients. The WCST taps into a cognitive domain (cognitive set shifting or flexibility) that may plausibly relate to the quantified dynamic network flexibility measure and has previously been related to the genetic predisposition to schizophrenia (32) .
Prior empirical data and theoretical accounts converge on the idea that altered oscillatory activity, temporal coordination, and excitatory-inhibitory balance of neural networks have a central role in the pathophysiology of schizophrenia (5-7). Specifically, building on the widespread topological network alteration observed in schizophrenia (33) , it is assumed that the alterations in the temporal organization of the brain functional connectome represent a widely distributed, rather than a regionally circumscribed, impairment (6, 24) . Although methodological differences between electrophysiology and fMRI-based network approaches call for a cautious interpretation, our results are in line with previously described global effects. The temporal coordination of node allegiances to neural systems is at the core of the quantified network flexibility measure, and our node-wise supplemental analyses highlighted a systemwide (rather than a regionally confined) increase in network flexibility in the patients and relatives. However, these findings do not argue against a differential or preferential involvement of certain brain areas at different hierarchical levels (34) . For the proposed excitatory-inhibitory imbalance of neural networks in schizophrenia, altered NMDA receptor-depending input to fast-spiking γ-aminobutyric acid (GABA) interneurons has been repeatedly highlighted as a key molecular candidate mechanism for schizophrenia (5, 25, 35, 36) . Indeed, prefrontal executive functions are critically regulated by NMDA receptor signaling (37, 38) , and a hypofunction of NMDA receptors has been implicated in the cognitive impairments (39, 40) and the underlying genetic risk architecture (35, 36) of schizophrenia.
Third, specifically to probe the question of whether alterations in NMDA receptor signaling impact the proposed dynamic network intermediate phenotype, we conducted a pharmacological challenge experiment consisting of a single dose of an NMDA receptor antagonist before fMRI. Under DXM, we observed a significant reorganization of the dynamic configuration of the functional connectome in the working memory challenge. Specifically, the data pointed to a drug-induced "network hyperflexibility" in the hypoglutamatergic state, a direction of change that is consistent with patients with schizophrenia and the healthy at-risk individuals. Notably, the phfMRI protocol followed an observer-blinded, placebo-controlled, randomized, cross-over design, and other critical variables, such as n-back task performance, head micromovement, and fMRI data quality, were comparable between the sessions. These circumstances makes the influence of secondary confounders on the observed drug effect unlikely explanations. Instead, the data conform to popular theories assuming a critical role for NMDA receptor function in the excitatory-inhibitory balance and temporal coordination of neural networks (6, 24, 25) and related connectivity alterations in schizophrenia (1, 6, 24, 25) , and might indicate a plausible molecular mechanism for the putative genetic risk-associated dynamic network phenotype we identified in this work.
Fourth, in the context of prior empirical data and theoretical accounts, the combined results of our experiments might offer a conceptual means of linking network properties to underlying molecular and cellular pathways: The transient communications patterns between distant regions (which we measure by network flexibility) are established through synchronous firing of mostly long-range pyramidal glutamatergic neurons. The activity of these neurons is regulated via a feedback loop involving fast-spiking inhibitory and parvalbumin (PV)-containing interneurons, which regulate the firing rate of the long-range pyramidal glutamatergic neurons through GABAergic input (8, 41) . This feedback loop is dependent on NMDA receptor functioning, because input from the long-range pyramidal glutamatergic neurons into the PV interneurons is transduced via NMDA receptors. As outlined above, an altered NMDA receptor-depending input to those fast-spiking GABAergic interneurons has been repeatedly highlighted as a key candidate mechanism in schizophrenia pathophysiology. Uhlhaas and Singer (6) propose that a hampered feedback loop leads to asynchronous firing of long-range pyramidal neurons and, consequently, to impaired synchrony between two distant brain regions (5, 6) . The impaired synchrony is believed to translate to more time-variant connectivity patterns between brain regions, which may plausibly result in a less stable community structure of the network in schizophrenia and after NMDA receptor blockade.
Our study has several limitations worth noting. First, although our sample sizes were relatively large and the observed effects were consistent across a range of analyses, we cannot fully rule out that our findings in the first-degree relatives may reflect familial rather than genetic influences. Second, we cannot rule out that in addition to NMDA receptor blockade, the mechanism of action of DXM involved partial binding to other receptor types (e.g., σ1, serotonin transporter). However, DXM binds to the same receptors as ketamine (42) , and the applied dose results in brain concentrations similar to the brain concentrations evoking an NMDA receptor block in vitro (43) (44) (45) . Third, although we demonstrate similar alterations in network reconfiguration in patients with schizophrenia, healthy first-degree relatives, and healthy subjects receiving a single dose of an NMDA receptor antagonist, this observation does not definitively prove that both phenomena are provoked by the same underlying biological mechanism or that NMDA receptors have a causal role in generating the schizophrenia-related network alterations. Here, further research is warranted, including pharmacological experiments in schizophrenia patients and their healthy first-degree relatives. Fourth, although the idea of an excitatoryinhibitory imbalance is a popular concept in current psychiatric neuroscience (34, 46) , the biological mechanisms require further clarification. Specifically, although the ubiquitous presence of glutamatergic neurons and NMDA receptors across the brain makes distributed genetic risk effects at the neural network level plausible, further translational research is needed to dissolve some of the ambiguities of this pathophysiological concept. Finally, although the applied dynamic network neuroscience methods are innovative and have gained increasing impetus in the neuroscience community recently (16, 18, 47, 48) , more work is needed to define the relative similarities and differences in the reconfiguration of dynamic neural networks in healthy individuals and clinical populations under different empirical contexts with different behavioral demands.
In summary, we provide evidence for a potential dynamic network intermediate phenotype for schizophrenia manifesting as a "hyperflexible" configuration of the brain functional connectome during working memory function. We provide evidence that the phenotype is a possible indicator of the genetic liability to schizophrenia, and is modulated by NMDA receptor antagonism in a way that conforms to existing concepts of a critical role for NMDA receptor input for the temporal organization of neural networks and related impairments in the pathophysiology of schizophrenia. Finally, our data may provide a valuable basis for the identification of the genetic contributions to the more proximal glutamatergic mechanisms of altered neural network dynamics and suggest a useful system-level target for the study of the effects of novel and established antipsychotic treatments.
Methods
Participants, Data Acquisition, and Preprocessing. All participants provided written informed consent for protocols approved by the Institutional Review Boards of the Medical Faculty Mannheim of the University of Heidelberg, the Medical Faculty of the University of Bonn, and the Charité-University Medicine Berlin. A total of 337 subjects (165 healthy controls, 50 first-degree relatives, 81 patients with schizophrenia, and an additional sample of 41 healthy controls for the phfMRI experiment) were included in this study (details and the supporting information for a detailed description of the recruitment and inclusion criteria are provided in Tables S1-S4 ). Further processing, quality control, and balancing (methods details are provided below) left a total of 204 subjects for the genetic risk analysis (139 healthy controls, 37 first-degree relatives, and 28 patients with schizophrenia) and 37 healthy controls for the phfMRI experiment.
Blood oxygen level-dependent fMRI was acquired for all subjects while performing an established n-back working memory task (49) . Details on the task, acquisition parameters, and quality assurance measures can be found in SI Methods. Functional image preprocessing of the working memory task was performed in SPM8 using previously described (4, 22, 23) standard procedures. We then extracted the mean time series from 5-mm spheres that were centered at 270 published peak coordinates and corrected it for signals from white matter and cerebrospinal fluid, as well as the six head motion parameters from the realignment step by regression as previously described (23, 50) . To minimize the potential for artificial inflation of coherence estimates, we removed the mean effects of the task conditions by regression (4, 18, 23) . In addition, because in-scanner head motion poses a severe problem for dynamic functional connectivity analysis, all frames of the time series with a frame-wise displacement of >0.5 mm were scrubbed and interpolated using spline interpolation. Further, all subjects with more than 5% of scrubbed frames after correction were excluded from the analysis.
Estimation of Network Connectivity and Identification of Putative Functional
Communities. For the connectivity analysis, we first applied a sliding time window with a length of 15 vol (51) [and no gap between the windows (16, 18) ] to all node time series. We then used wavelet coherence to estimate the functional connectivity between each pair of brain nodes using the MATLAB (MathWorks) package for cross-wavelet and wavelet coherence analysis (52), as described previously (16, 18, 48) . For each subject, this estimation yielded 114 (or 109 in the pharmacological challenge study) weighted matrices describing the functional connectivity in each time window during the n-back task performance. For each subject, the resulting coherence matrices were partitioned into time-dependent communities using a multilayer community detection algorithm based on a Louvain-like locally greedy optimization method to maximize the modularity quality function (15, 16, 18, 48) . For each optimization, we calculated a time-dependent network flexibility matrix (18), F, whose binary elements, F ij , indicate whether (1) or not (0) a node i changes its community at the transition j between two consecutive time windows. Individual whole-brain network flexibility estimates were obtained by averaging the mean network flexibility matrix over time windows and over brain regions.
Supplemental Machine Learning Analysis. Random forest machine learning was used to identify combinations of nodes that could optimally differentiate between patients with schizophrenia and controls (53) . Details are provided in SI Methods.
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